PATENT CLAIM ANALYSIS

Application Number: 16009303
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "04400A"]

Abstract:
The present invention regards oligonucleotides for modulating the expression of a gene, in particular for modulating a gene responsible for a pathology of genetic, tumoural or viral origin. Moreover, the present invention relates to the use of said oligonucleotides, possibly chemically modified, for the treatment and/or the diagnosis of said diseases.

Claim (Index 15):
The method according to  claim 12 , wherein SEQ ID NO: 75, 76, are directed against the gene BIRC5.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 94.0
- Lexical Diversity: 1.65714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14780043', '14533371', '15882221', '15364050', '15222695']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7310533277496668
- 35 USC 102 Novelty (BERT): 0.5197125006691375
- Combined Prediction Score: 0.7099192450416139
- Mean Citation Score: 236.347142
- Max Citation Score: 246.64674
- Similarity Product: 148.89514895771023

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test